Absci (ABSI) Operating Income (2020 - 2026)
Absci's (ABSI) quarterly Operating Income came in at -$30.8 million in Q1 2026, down 11.24% year-on-year from -$34.8 million in Q1 2025, and up 0.63% quarter-over-quarter from -$31.0 million in Q4 2025.
Absci (ABSI) Operating Income (2020 - 2026) Analysis & Trends
Absci has disclosed Operating Income across 7 years of filings, most recently posting -$30.8 million for Q1 2026.
- Operating Income for Q1 2026 came in at -$30.8 million, down 11.24% year-over-year; the trailing twelve-month figure through Mar 2026 was -$123.4 million (down 9.12% YoY), and the FY2025 annual result was -$120.3 million, down 10.5% from the prior year.
- Operating Income came in at -$30.8 million for Q1 2026 at Absci, up from -$31.0 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of -$21.1 million in Q4 2022 to a low of -$43.0 million in Q2 2023.
- The 5-year median for Operating Income is -$28.8 million (2022), against an average of -$28.4 million.
- Across the five-year window, Operating Income tumbled 158.37% in 2022 and soared 37.84% in 2024, its largest moves.
- Absci's Operating Income stood at -$21.1 million in 2022, then fell by 17.29% to -$24.7 million in 2023, then declined by 20.35% to -$29.8 million in 2024, then slipped by 4.26% to -$31.0 million in 2025, then advanced by 0.63% to -$30.8 million in 2026.
- The last three Operating Income figures came in at -$30.8 million (Q1 2026), -$31.0 million (Q4 2025), and -$30.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | -30.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.85 Mn |
| Dec 31, 2025 | -31.04 Mn |
| Sep 30, 2025 | -30.15 Mn |
| Jun 30, 2025 | -31.39 Mn |
| Mar 31, 2025 | -27.73 Mn |
| Dec 31, 2024 | -29.77 Mn |
| Sep 30, 2024 | -28.90 Mn |
| Jun 30, 2024 | -26.72 Mn |
| Mar 31, 2024 | -23.50 Mn |
| Dec 31, 2023 | -24.74 Mn |
| Sep 30, 2023 | -23.30 Mn |
| Jun 30, 2023 | -42.99 Mn |
| Mar 31, 2023 | -24.49 Mn |
| Dec 31, 2022 | -21.09 Mn |
| Sep 30, 2022 | -27.97 Mn |
| Jun 30, 2022 | -28.89 Mn |
| Mar 31, 2022 | -28.80 Mn |
| Dec 31, 2021 | -26.26 Mn |
| Sep 30, 2021 | -21.14 Mn |
| Jun 30, 2021 | -16.69 Mn |